resveratrol has been researched along with Ototoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J | 1 |
| Azman, M; Kılıç, R; Muluk, NB; Simsek, G; Taş, BM | 1 |
| He, J; Liu, Y; Wu, H; Yang, J; Zhang, F | 1 |
3 other study(ies) available for resveratrol and Ototoxicity
| Article | Year |
|---|---|
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2022 |
Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
Topics: Animals; Antineoplastic Agents; Cisplatin; Dexamethasone; Hearing Loss; Injection, Intratympanic; Male; Otoacoustic Emissions, Spontaneous; Ototoxicity; Rats; Resveratrol | 2019 |
Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cisplatin; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Ototoxicity; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol | 2021 |